Recursion Pharmaceuticals, Inc. insider trades
as of filings through Nov 4, 2026
- Bought
- $0
- 0 trades, 0 insiders
- Sold
- $601K
- 4 trades, 3 insiders
- Net
- −$601K
- since Sep 10, 2026
- Under 10b5-1 plans
- 4
- of 4 sales
FiledStockInsiderSideValueSharesAvg priceTraded
More on RXRX
RXRX against its rivals
No comparison pages for RXRX.